Qureight Limited
- Diagnostics
- Medical device or technology
Qureight is a data analytics company which uses machine learning to revolutionise drug development in lung and heart disease. Built on proprietary source data, our world-leading imaging platform allows us to create AI-based products that our clients use to accelerate clinical trials e.g. workflow tools, synthetic trial arms, endpoint analytics and companion biomarkers.
Our flagship product is AI lung, a suite of 3D imaging tools which mirror lung physiology and are now being used as image-based endpoints in global phase 2 and 3 clinical trials in Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary Hypertension (PH). Qureight’s models can diagnose and track these diseases more effectively and earlier than expert clinicians.